Tag: Zydus Cadila

Zydus Cadila gets DCGI approval to initiate Phase-3 clinical trials for COVID-19 vaccine

NEW DELHI: Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that it will be starting Phase III clinical trials of it plasmid DNA vaccine to prevent COVID-19, ZyCoV-D after having received permissions from the DCGI. The company will now be initiating Phase III […]

Zydus Cadila receives tentative approval from USFDA for Dapagliflozin Tablets

NEW DELHI: Zydus Cadila said that it has received tentative approval from the USFDA to market Dapagliflozin Tablets, 5 mg and 10 mg (US RLD: Farxiga Tablets). Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and […]

Back To Top